Antibacterial activity of cefoperazone and cefoperazone plus sulbactam in a neutropenic site model
- 30 April 1991
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 14 (2) , 147-155
- https://doi.org/10.1016/0732-8893(91)90050-p
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- β‐Lactamase InhibitorsPublished by Wiley ,2000
- Resistance to β-lactams in Gram-negative bacteria: relative contributions of β-lactamase and permeability limitationsJournal of Antimicrobial Chemotherapy, 1987
- In vivo and in vitro activity of ciprofloxacin plus azlocillin against 12 streptococcal isolates in a neutropenic site modelDiagnostic Microbiology and Infectious Disease, 1987
- Ceftazidime and amikacin alone and in combination against Pseudomonas aeruginosa and EnterobacteriaceaeDiagnostic Microbiology and Infectious Disease, 1987
- Sulbactam: Biochemical Factors Involved in Its Synergy with AmpicillinClinical Infectious Diseases, 1986
- Induction/Inhibition of Chromosomal β-Lactamases by β-Lactamase InhibitorsClinical Infectious Diseases, 1986
- Ciprofloxacin, azlocilin, ceftizoxime and amikacin alone and in combination against Gram-negative bacilli in an infected chamber modelJournal of Antimicrobial Chemotherapy, 1986
- In vitro antimicrobial activity of cefoperazone-sulbactam combinations against 554 clinical isolates including a review and β-lactamase studiesDiagnostic Microbiology and Infectious Disease, 1985
- Cefoperazone: A Review of Its Antimicrobial Spectrum, β-Lactamase Stability, Enzyme Inhibition, and Other in Vitro CharacteristicsClinical Infectious Diseases, 1983
- Synergistic activity of cefoperazone in combination with β-lactamase inhibitorsJournal of Antimicrobial Chemotherapy, 1981